Wealth Group’s AbbVie ABBV Stock Holding History

Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.03M	Buy	12,050 +8,101	+205%	+$1.74M	0.76%	34
2026 Q1	$859K	Buy	3,949 +215	+6%	+$47.7K	0.8%	36
2025 Q4	$853K	Buy	+3,734	New	+$851K	0.83%	35
2025 Q2	$741K	Sell	3,991 -1,213	-23%	-$225K	0.74%	38
2025 Q1	$1.09M	Buy	5,204 +327	+7%	+$63.6K	0.71%	37
2024 Q4	$867K	Buy	4,877 +44	+0.9%	+$8.09K	0.56%	43
2024 Q3	$955K	Sell	4,833 -60	-1%	-$11.2K	0.64%	40
2024 Q2	$839K	Sell	4,893 -338	-6%	-$56K	0.6%	43
2024 Q1	$952K	Buy	+5,231	New	+$902K	0.72%	39

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wealth Group's ABBV Position: Q2 2026 in Review

Wealth Group increased its AbbVie (ABBV) stake by 205% in Q2 2026, buying an estimated $1.74M and bringing the position to 12,050 shares worth $3.03M. The position accounts for 0.76% of the portfolio, ranked #34.

Wealth Group first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wealth Group held 12,050 shares of AbbVie worth $3.03M as of Q2 2026.
Wealth Group bought 8,101 AbbVie shares in Q2 2026, an estimated $1.74M.
AbbVie made up 0.76% of Wealth Group's portfolio in Q2 2026, its #34 holding.
Wealth Group first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Group's 13F filing for Q2 2026, filed 21 Jul 2026.